Clinical Trials Browser

Terminated × duvelisib × 90 days × Clear all

NCT04331119 2026-05-06

Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas

Phase 2 Terminated

Lymphoma, T-Cell